These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33307558)

  • 61. Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients.
    Fragoso MC; Almeida MQ; Mazzuco TL; Mariani BM; Brito LP; Gonçalves TC; Alencar GA; Lima Lde O; Faria AM; Bourdeau I; Lucon AM; Freire DS; Latronico AC; Mendonca BB; Lacroix A; Lerario AM
    Eur J Endocrinol; 2012 Jan; 166(1):61-7. PubMed ID: 22048964
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Decoding the crosstalk between mevalonate metabolism and T cell function.
    Kennewick KT; Bensinger SJ
    Immunol Rev; 2023 Aug; 317(1):71-94. PubMed ID: 36999733
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
    O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
    Miner Electrolyte Metab; 1993; 19(3):173-9. PubMed ID: 8232104
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
    Faria AM; Almeida MQ
    Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS; Panini SR
    Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential expression of parathyroid hormone-related protein in adrenocortical tumors: autocrine/paracrine effects on the growth and signaling pathways in H295R cells.
    Rizk-Rabin M; Assie G; Rene-Corail F; Perlemoine K; Hamzaoui H; Tissier F; Lieberherr M; Bertagna X; Bertherat J; Bouizar Z
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2275-85. PubMed ID: 18768493
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
    De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incomplete Pattern of Steroidogenic Protein Expression in Functioning Adrenocortical Carcinomas.
    Pereira SS; Costa MM; Gomez-Sanchez CE; Monteiro MP; Pignatelli D
    Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32751564
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Circular RNA circ-CCAC1 Facilitates Adrenocortical Carcinoma Cell Proliferation, Migration, and Invasion through Regulating the miR-514a-5p/C22orf46 Axis.
    Li W; Liu R; Wei D; Zhang W; Zhang H; Huang W; Hao L
    Biomed Res Int; 2020; 2020():3501451. PubMed ID: 33195693
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin.
    Griffin S; Preta G; Sheldon IM
    Sci Rep; 2017 Dec; 7(1):17050. PubMed ID: 29213055
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.
    Brown TC; Nicolson NG; Stenman A; Juhlin CC; Gibson CE; Callender GG; Korah R; Carling T
    J Am Coll Surg; 2019 Sep; 229(3):305-315. PubMed ID: 31034883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.
    Faria AM; Sbiera S; Ribeiro TC; Soares IC; Mariani BM; Freire DS; de Sousa GR; Lerario AM; Ronchi CL; Deutschbein T; Wakamatsu A; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Fassnacht M; Almeida MQ
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):481-8. PubMed ID: 25200669
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis.
    Buechler RD; Peffley DM
    Mol Carcinog; 2004 Sep; 41(1):39-53. PubMed ID: 15352124
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non-Small Cell Lung Carcinogenesis.
    Zhang T; Bai R; Wang Q; Wang K; Li X; Liu K; Ryu J; Wang T; Chang X; Ma W; Bode AM; Xia Q; Song Y; Dong Z
    Cancer Prev Res (Phila); 2019 Dec; 12(12):837-848. PubMed ID: 31554629
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.
    Uchida T; Nishimoto K; Fukumura Y; Asahina M; Goto H; Kawano Y; Shimizu F; Tsujimura A; Seki T; Mukai K; Kabe Y; Suematsu M; Gomez-Sanchez CE; Yao T; Horie S; Watada H
    Endocr Pathol; 2017 Mar; 28(1):27-35. PubMed ID: 27430645
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer.
    Szabó DR; Baghy K; Szabó PM; Zsippai A; Marczell I; Nagy Z; Varga V; Éder K; Tóth S; Buzás EI; Falus A; Kovalszky I; Patócs A; Rácz K; Igaz P
    Cell Mol Life Sci; 2014 Mar; 71(5):917-32. PubMed ID: 23807211
    [TBL] [Abstract][Full Text] [Related]  

  • 78. p53 regulates the mevalonate pathway in human glioblastoma multiforme.
    Laezza C; D'Alessandro A; Di Croce L; Picardi P; Ciaglia E; Pisanti S; Malfitano AM; Comegna M; Faraonio R; Gazzerro P; Bifulco M
    Cell Death Dis; 2015 Oct; 6(10):e1909. PubMed ID: 26469958
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
    Liang R; Weigand I; Lippert J; Kircher S; Altieri B; Steinhauer S; Hantel C; Rost S; Rosenwald A; Kroiss M; Fassnacht M; Sbiera S; Ronchi CL
    Front Endocrinol (Lausanne); 2020; 11():219. PubMed ID: 32373071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3beta-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities.
    Samandari E; Kempná P; Nuoffer JM; Hofer G; Mullis PE; Flück CE
    J Endocrinol; 2007 Dec; 195(3):459-72. PubMed ID: 18000308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.